Articles published by Abivax
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax Provides Operational and Key Program Update
July 15, 2024
From Abivax
Via GlobeNewswire
Tickers
ABVX
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
June 04, 2024
From Abivax
Via GlobeNewswire
Tickers
ABVX
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax reports 2023 financial results and operational update
April 02, 2024
From Abivax
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax appoints Ana Sharma as Vice President, Global Head of Quality
February 07, 2024
From Abivax
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months
January 22, 2024
From Abivax
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
![](https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png)
Abivax announces the resumption of its liquidity contract
November 21, 2023
From Abivax
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
From Abivax
Via GlobeNewswire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
Abivax Reports 2021 Financial Results and Operations Update
March 16, 2022
From ABIVAX
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
From ABIVAX
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
Abivax Receives EMA Scientific Advice Supportive of Moving ABX464 into Phase 3 Clinical Testing in Ulcerative Colitis
January 13, 2022
From ABIVAX
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
Abivax to Present at the J.P. Morgan 40th Annual Healthcare Conference
December 15, 2021
From ABIVAX
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
Abivax Receives FDA Feedback with Guidance on Advancing ABX464 into Phase 3 Clinical Testing in Ulcerative Colitis
December 01, 2021
From ABIVAX
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif?v=0)
ABIVAX: ABX464 shows excellent long-term efficacy data in Abivax's phase 2b maintenance Trial in ulcerative colitis
October 18, 2021
From ABIVAX
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/17711.gif)
Abivax Late-Breaking Abstract Presentation and Live Industry Symposium at the UEG Week Virtual 2021
September 28, 2021
From ABIVAX
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.